EUDA Health (NASDAQ:EUDA) Shares Scheduled to Reverse Split on Monday, March 23rd

EUDA Health Holdings Limited (NASDAQ:EUDA)’s stock is set to reverse split before the market opens on Monday, March 23rd. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, March 22nd.

EUDA Health Trading Down 15.2%

Shares of EUDA traded down $0.07 during mid-day trading on Thursday, reaching $0.40. The company’s stock had a trading volume of 472,240 shares, compared to its average volume of 149,615. EUDA Health has a 1-year low of $0.36 and a 1-year high of $4.30. The business has a 50-day simple moving average of $1.11 and a two-hundred day simple moving average of $1.93. The stock has a market cap of $15.07 million, a P/E ratio of -3.32 and a beta of -0.11.

Wall Street Analyst Weigh In

Several brokerages have issued reports on EUDA. Weiss Ratings reaffirmed a “sell (d)” rating on shares of EUDA Health in a report on Friday, January 9th. Greenridge Global decreased their price objective on shares of EUDA Health from $6.00 to $2.75 and set a “buy” rating on the stock in a report on Monday, March 9th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $2.75.

Institutional Inflows and Outflows

An institutional investor recently raised its position in EUDA Health stock. Citadel Advisors LLC increased its position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 44,631 shares of the company’s stock after purchasing an additional 16,321 shares during the quarter. Citadel Advisors LLC owned 0.12% of EUDA Health worth $78,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 4.35% of the company’s stock.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.